AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
Top Cited Papers
- 1 April 2011
- journal article
- Published by Elsevier in Cell Metabolism
- Vol. 13 (4) , 376-388
- https://doi.org/10.1016/j.cmet.2011.03.009
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBPGenes & Development, 2010
- Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK ActivationPublished by Elsevier ,2010
- Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesisProceedings of the National Academy of Sciences, 2010
- SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein KinaseJournal of Biological Chemistry, 2008
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointPublished by Elsevier ,2008
- From fatty streak to fatty liver: 33 years of joint publications in the JCIJournal of Clinical Investigation, 2008
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Insulin resistance and atherosclerosisJournal of Clinical Investigation, 2006
- 5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor MicroenvironmentsMolecular and Cellular Biology, 2006
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001